Skip to content

Panagiotis Afouxenidis, DDS

NPI 1891459707ActiveIndividual· Dentist, Periodontics· Dallas, TX

Dentist, Periodontics (DDS) in Dallas, Texas, licensed in TX, with an NPI issued in October 2021. Part D covered 44 prescriptions written in 2024, 100% of them generic. Geistlich Pharma, North America, Inc. reported $215.86 in payments in 2025, mostly food and beverage.

Overview

NPI1891459707
StatusActive
Entity typeIndividual
CredentialDDS
Sole proprietorNo
NPI issuedOct 26, 2021
Last updated in NPPESJan 23, 2025
Certified by providerJan 23, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Dentist, Periodontics Primary1223P0300X39760TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)44 · 44 30-day fills
Patients14
Total drug cost$161.14
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$215.86 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Geistlich Pharma, North America, Inc.$215.861

What the 2025 payments were for

  • Food and Beverage$215.86 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Dentist, Periodontics providers in Dallas

All Dentist, Periodontics providers in Texas →